Skip to main content
Top
Published in: World Journal of Surgery 11/2016

01-11-2016 | Original Scientific Report

Preoperative Left Portal Vein Embolization for Left Liver Resection in High-Risk Hepatobiliary Malignancy Patients

Authors: Shin Hwang, Gi-Young Ko, Myeong-Hwan Kim, Sung-Koo Lee, Dong-Il Gwon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Do Hyun Park, Sang Soo Lee

Published in: World Journal of Surgery | Issue 11/2016

Login to get access

Abstract

Background

Preoperative portal vein embolization (PVE) is performed for right liver (RL) and sometimes left liver (LL) resection to prevent postoperative surgical complications.

Methods

We retrospectively reviewed 10 patients who underwent preoperative left PVE before LL resection for hepatobiliary malignancies along with 3 propensity score-matched control groups (n = 40 each).

Results

Mean patient age was 68.6 ± 6.9 years. Diagnoses included intrahepatic cholangiocarcinoma (n = 4), perihilar cholangiocarcinoma (n = 3), neuroendocrine carcinoma (n = 1), recurrent cholangiocarcinoma (n = 1), and inflammatory liver mass (n = 1). The reason for left PVE was a large LL >40 % of the total liver volume (TLV) with a major comorbidity or age > 70 years with a poor overall condition. All patients underwent preplanned operations, including LL resection at 1–3 weeks post PVE. The LL volume proportion of the TLV was 44.9 ± 1.7 and 40.7 ± 2.3 % before and after PVE; thus, 1–2 weeks post PVE, the kinetic shrinkage rate of the LL was 9.4 ± 3.3 %, and the kinetic growth rate of the RL was 7.6 ± 2.7 %. The overall surgical complication rates were 40, 50, and 39.2 % in the left PVE, large LL control, and all three control groups, respectively (p ≥ 0.727). In contrast, the adjusted rates of major complications were 0 % in the left PVE group versus 36.8 % (p = 0.040), 25.6 % (p = 0.123), and 15.8 % (p = 0.295) in the large-, medium-, and small-sized LL control groups, respectively.

Conclusions

Our experience indicates that left PVE is safe and induces atrophy of the LL effectively. We suggest that it can be a useful option to reduce the risk of postoperative complications in elderly high-risk patients.
Literature
1.
go back to reference Yokoyama Y, Nagino M, Nimura Y (2007) Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 31:367–374CrossRefPubMed Yokoyama Y, Nagino M, Nimura Y (2007) Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 31:367–374CrossRefPubMed
2.
go back to reference Shindoh J, Truty MJ, Aloia TA et al (2013) Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216:201–209CrossRefPubMed Shindoh J, Truty MJ, Aloia TA et al (2013) Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216:201–209CrossRefPubMed
3.
go back to reference Lee SG, Hwang S (2005) How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg 12:38–43CrossRefPubMed Lee SG, Hwang S (2005) How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg 12:38–43CrossRefPubMed
4.
go back to reference Hwang S, Ha TY, Song GW et al (2015) Quantified risk assessment for major hepatectomy via the indocyanine green clearance rate and liver volumetry combined with standard liver volume. J Gastrointest Surg 19:1305–1314CrossRefPubMed Hwang S, Ha TY, Song GW et al (2015) Quantified risk assessment for major hepatectomy via the indocyanine green clearance rate and liver volumetry combined with standard liver volume. J Gastrointest Surg 19:1305–1314CrossRefPubMed
5.
go back to reference Hwang S, Ha TY, Ko GY et al (2015) Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg 39:2990–2998CrossRefPubMed Hwang S, Ha TY, Ko GY et al (2015) Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg 39:2990–2998CrossRefPubMed
6.
go back to reference Harimoto N, Yoshizumi T, Shimokawa M et al (2016) Sarcopenia is a poor prognostic factor following hepatic resection in patients 70 years of age and older with hepatocellular carcinoma. Hepatol Res (in press) Harimoto N, Yoshizumi T, Shimokawa M et al (2016) Sarcopenia is a poor prognostic factor following hepatic resection in patients 70 years of age and older with hepatocellular carcinoma. Hepatol Res (in press)
7.
go back to reference Sulpice L, Rayar M, Campillo B et al (2014) Advanced age remains an Achilles heel for liver resections. World J Surg 38:918–926CrossRefPubMed Sulpice L, Rayar M, Campillo B et al (2014) Advanced age remains an Achilles heel for liver resections. World J Surg 38:918–926CrossRefPubMed
8.
go back to reference Schiergens TS, Lindenthaler A, Thomas MN et al (2016) Time-dependent impact of age and co-morbidities on long-term overall survival after liver resection. Liver Int (in press) Schiergens TS, Lindenthaler A, Thomas MN et al (2016) Time-dependent impact of age and co-morbidities on long-term overall survival after liver resection. Liver Int (in press)
9.
go back to reference Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed
10.
11.
go back to reference Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
12.
go back to reference Ko GY, Sung KB, Yoon HK et al (2003) Preoperative portal vein embolization with a new liquid embolic agent. Radiology 227:407–413CrossRefPubMed Ko GY, Sung KB, Yoon HK et al (2003) Preoperative portal vein embolization with a new liquid embolic agent. Radiology 227:407–413CrossRefPubMed
13.
go back to reference Yoo H, Ko GY, Gwon DI et al (2009) Preoperative portal vein embolization using an amplatzer vascular plug. Eur Radiol 19:1054–1061CrossRefPubMed Yoo H, Ko GY, Gwon DI et al (2009) Preoperative portal vein embolization using an amplatzer vascular plug. Eur Radiol 19:1054–1061CrossRefPubMed
14.
go back to reference Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRefPubMed
15.
go back to reference Yoon YI, Hwang S, Ko GY et al (2015) Balloon dilation of jejunal afferent loop functional stenosis following left hepatectomy and hepaticojejunostomy long time after pylorus-preserving pancreaticoduodenectomy: a case report. Korean J Hepatobiliary Pancreat Surg 19:66–70CrossRefPubMedPubMedCentral Yoon YI, Hwang S, Ko GY et al (2015) Balloon dilation of jejunal afferent loop functional stenosis following left hepatectomy and hepaticojejunostomy long time after pylorus-preserving pancreaticoduodenectomy: a case report. Korean J Hepatobiliary Pancreat Surg 19:66–70CrossRefPubMedPubMedCentral
16.
go back to reference Komori K, Nagino M, Nimura Y (2006) Hepatocyte morphology and kinetics after portal vein embolization. Br J Surg 93:745–751CrossRefPubMed Komori K, Nagino M, Nimura Y (2006) Hepatocyte morphology and kinetics after portal vein embolization. Br J Surg 93:745–751CrossRefPubMed
17.
go back to reference Lee SG, Song GW, Hwang S et al (2010) Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci 17:476–489CrossRefPubMed Lee SG, Song GW, Hwang S et al (2010) Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci 17:476–489CrossRefPubMed
18.
go back to reference Hwang S, Lee SG, Ko GY et al (2009) Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg 249:608–616CrossRefPubMed Hwang S, Lee SG, Ko GY et al (2009) Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg 249:608–616CrossRefPubMed
19.
go back to reference Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term followup. Ann Surg 243:364–372CrossRefPubMedPubMedCentral Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term followup. Ann Surg 243:364–372CrossRefPubMedPubMedCentral
20.
go back to reference Hayashi S, Baba Y, Ueno K et al (2007) Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol 48:721–727CrossRefPubMed Hayashi S, Baba Y, Ueno K et al (2007) Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol 48:721–727CrossRefPubMed
21.
go back to reference Yoo H, Kim JH, Ko GY et al (2011) Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 18:1251–1257CrossRefPubMed Yoo H, Kim JH, Ko GY et al (2011) Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 18:1251–1257CrossRefPubMed
Metadata
Title
Preoperative Left Portal Vein Embolization for Left Liver Resection in High-Risk Hepatobiliary Malignancy Patients
Authors
Shin Hwang
Gi-Young Ko
Myeong-Hwan Kim
Sung-Koo Lee
Dong-Il Gwon
Tae-Yong Ha
Gi-Won Song
Dong-Hwan Jung
Do Hyun Park
Sang Soo Lee
Publication date
01-11-2016
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 11/2016
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3618-7

Other articles of this Issue 11/2016

World Journal of Surgery 11/2016 Go to the issue